Clinical Trials on Residual Invasive Breast Cancer
Total 11845 results
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
Instituto Nacional de Ciencias Medicas y Nutricion...UnknownTriple-Negative Invasive Breast Carcinoma | Residual TumorMexico
-
Lumicell, Inc.National Cancer Institute (NCI)Completed
-
University Health Network, TorontoCompletedBreast Cancer Invasive Nos | Primary Invasive Breast CancerCanada
-
Shandong Cancer Hospital and InstituteNot yet recruitingHER2-positive Breast Cancer
-
Dana-Farber Cancer InstitutePfizerCompletedBreast Cancer Stage IV | Unresectable Locally Advanced Invasive Breast Cancer | Metastatic Invasive Breast CancerUnited States
-
Dana-Farber Cancer InstituteBeth Israel Deaconess Medical Center; Hoffmann-La Roche; Brigham and Women's...TerminatedStage I Breast Cancer | Stage II Breast Cancer | Invasive Breast Carcinoma | Stage III Breast Cancer | Primary Invasive Breast CancerUnited States
-
Personalis Inc.RecruitingMinimal Residual Disease | TNBC - Triple-Negative Breast CancerUnited States
-
Dana-Farber Cancer InstituteGenentech, Inc.; Stand Up To CancerActive, not recruitingBreast Cancer | Triple Negative Breast Cancer | Circulating Tumor DNA | Residual CancerUnited States
-
Hoffmann-La RocheNSABP Foundation Inc; German Breast GroupActive, not recruitingBreast CancerUnited States, Italy, United Kingdom, Canada, Czechia, Argentina, Austria, Belgium, Brazil, China, France, Germany, Guatemala, Ireland, Panama, Spain, Sweden, Taiwan, Turkey, Colombia, Hong Kong, Peru, Switzerland, South Africa, Israel, G... and more
-
Abramson Cancer Center at Penn MedicineRecruitingBreast CancerUnited States
-
Mayo ClinicRecruitingBreast Cancer | ResidualUnited States
-
Massachusetts General HospitalTesaro, Inc.RecruitingTriple Negative Breast Cancer | Residual DiseaseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Active, not recruitingStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Lobular Breast Carcinoma | Invasive Ductal Breast CarcinomaUnited States, Puerto Rico
-
H. Lee Moffitt Cancer Center and Research InstituteAmgenActive, not recruitingBreast Cancer | Invasive Breast Carcinoma | Invasive Ductal Breast Carcinoma | Ductal CarcinomaUnited States
-
University of TriesteCompletedBladder Cancer | Non Muscle Invasive Bladder CancerItaly
-
University of Illinois at ChicagoRecruitingBreast Cancer Female | Breast Cancer InvasiveUnited States
-
Stanford UniversityNational Institutes of Health (NIH)RecruitingBreast Cancer | Breast Cancer Non-invasive Breast CancerUnited States
-
University of California, IrvineCompletedInvasive Breast Cancer | Incident Breast Cancer
-
National Cancer Center, KoreaRecruitingBreast Cancer | Invasive Breast CancerKorea, Republic of
-
University of Wisconsin, MadisonNational Center for Advancing Translational Sciences (NCATS)RecruitingInvasive Breast CancerUnited States
-
University of Kansas Medical CenterAstraZenecaCompletedInvasive Breast CancerUnited States
-
Shanghai Jiao Tong University School of MedicineJiangsu HengRui Medicine Co., Ltd.Active, not recruitingBreast Cancer InvasiveChina
-
Ronald WeigelAstraZenecaTerminatedInvasive Breast CancerUnited States
-
Columbia UniversityAvon FoundationCompletedInvasive Breast CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedInvasive Breast CancerUnited States
-
Ottawa Hospital Research InstituteUnknownBreast Cancer | Invasive Breast CancerCanada
-
BioNTech Diagnostics GmbHCompleted
-
NSABP Foundation IncGlaxoSmithKlineUnknownInvasive Breast CancerUnited States, Canada, Puerto Rico
-
Jewish General HospitalLaurentian UniversityCompletedInvasive Breast CancerCanada
-
University Medical Center GroningenMartini Hospital GroningenRecruitingBreast Cancer | Breast Cancer InvasiveNetherlands
-
RenJi HospitalRecruitingBreast Cancer InvasiveChina
-
Seoul National University HospitalMinistry of Health & Welfare, KoreaRecruitingBreast Cancer InvasiveKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterRecruitingBreast Cancer | Invasive Breast CancerUnited States
-
Peking UniversityRecruitingInvasive Breast CancerChina
-
Istari Oncology, Inc.United States Department of Defense; Duke UniversityCompleted
-
Medical College of WisconsinActive, not recruitingBreast Cancer | Invasive Breast CancerUnited States
-
Institut Claudius RegaudActive, not recruiting
-
Ohio State University Comprehensive Cancer CenterBarnes-Jewish HospitalCompletedInvasive Breast CancerUnited States
-
Massachusetts General HospitalNational Cancer Institute (NCI)UnknownInvasive Breast CancerUnited States
-
Peking UniversityCompletedInvasive Breast CancerChina
-
University of NottinghamAstraZeneca; Cancer Research UK; National Cancer Research NetworkCompleted
-
Centre hospitalier de l'Université de Montréal...Quebec Breast Cancer FoundationCompletedBreast Cancer | Invasive Breast CancerCanada
-
Peking UniversityNot yet recruitingInvasive Breast CancerChina
-
Seoul National University HospitalRecruitingBreast Cancer InvasiveKorea, Republic of
-
Case Comprehensive Cancer CenterRecruitingInvasive Breast CancerUnited States
-
Sunnybrook Health Sciences CentreRecruiting
-
Fondazione MichelangeloHoffmann-La RocheActive, not recruitingInvasive Breast CancerSpain, Italy, Germany, Austria
-
Institut Paoli-CalmettesActive, not recruitingInvasive Breast CancerFrance
-
Mayo ClinicActive, not recruiting